| Literature DB >> 35458601 |
Ioana-Miruna Balmus1, Dana Copolovici2, Lucian Copolovici2, Alin Ciobica3, Dragos Lucian Gorgan3.
Abstract
During and following the processing of a plant's raw material, considerable amounts are wasted, composted, or redistributed in non-alimentary sectors for further use (for example, some forms of plant waste contribute to biofuel, bioethanol, or biomass production). However, many of these forms of waste still consist of critical bioactive compounds used in the food industry or medicine. Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. The primary treatment is based on symptomatology alleviation and controlled dietary management. Thus, this review aimed to describe the possible relevance of molecules residing in plant waste that can be used to manage IBS and co-occurring symptoms. Significant evidence was found that many forms of fruit, vegetable, and medicinal plant waste could be the source of some molecules that could be used to treat or prevent stool consistency and frequency impairments and abdominal pain, these being the main IBS symptoms. While many of these molecules could be recovered from plant waste during or following primary processing, the studies suggested that enriched food could offer efficient valorization and prevent further changes in properties or stability. In this way, root, stem, straw, leaf, fruit, and vegetable pomaces were found to consist of biomolecules that could modulate intestinal permeability, pain perception, and overall gastrointestinal digestive processes.Entities:
Keywords: antioxidants; enzymes; fatty acids; fibers; fruits; hormones; irritable bowel syndrome; leaves; medicinal plant; plant wastes; pomace; seeds; vitamins
Mesh:
Year: 2022 PMID: 35458601 PMCID: PMC9024464 DOI: 10.3390/molecules27082403
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Pathological mechanisms of the main IBS symptomatology (according to ROME IV Diagnostic Criteria for functional gastrointestinal disorders) (NMDAR: NMDA receptor) [10,20,21,22,23,24,25,26,27].
Figure 2Biomolecules that are potentially relevant to IBS symptomatology management (molecular structures added using BIOVIA Draw 19 software, 2019 by San Diego: Dassault Systèmes and IUPAC names available on PubChem database).